Predict your next investment

Corporation
coopercos.com

See what CB Insights has to offer

Service Providers

1

About CooperCompanies

CooperCompanies is a global medical device company publicly traded on the NYSE Euronext (NYSE: COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to crafting a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical focuses on supplying women's health clinicians with market leading products and treatment options to improve the delivery of healthcare to women. Headquartered in Pleasanton, CA, Cooper has approximately 8,000 employees with products sold in over 100 countries.

CooperCompanies Headquarter Location

Pleasanton, California,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing CooperCompanies

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find CooperCompanies in 1 Expert Collection, including Medical Devices.

M

Medical Devices

295 items

Companies that received PMA from the FDA since 2014. Companies tagged as #FDAPMA

Latest CooperCompanies News

Global Spectacle Lens Market Report to 2030 - Featuring Carl Zeiss Meditec, Cooper Companies and Essilor International Among Others - ResearchAndMarkets.com

May 12, 2022

Warby Parker The market is expected to be driven by the increasing cases of eye disorder among elderly population coupled with the spectacle correction technology for myopia control. Furthermore, increasing demand of fashionable eyeglasses among customers are also estimated to fuel the market growth. Despite the driving factors, lack of required skills for ophthalmic laboratory technicians are anticipated to hinder the market growth. Growth Influencers: Increasing cases of eye disorder among elderly population According to the World Health Organization, as of October 2021, globally nearly 2.2 billion people suffer from a near or distance vision impairment. Leading causes of vision impairment are cataracts and uncorrected refractive errors. As per the same source, majority of these people are above the age of 50 years. Out of these 2.2 billion people, nearly 1 billion suffer from moderate or severe distance vision impairment or blindness. This is due to 84.4 million unaddressed refractive error patients, 7.7 million glaucoma patients, 94 million cataract patients, 3.9 million diabetic retinopathy patients, 4.2 million corneal opacities patients, 2 million trachoma patients, and about 826 million vision impairment caused by unaddressed presbyopia patients. Hence, increasing cases of eye disorders, especially among elderly population is expected to create awareness regarding eye testing, hence boosting the demand for spectacle lens. Segments Overview: By Type Hospitals The online segment is expected to register the highest CAGR of about 6.2% during the projected period owing to the rising number of e-commerce platforms, solely focused on eyewear. For instance, Lenskart in India is a well-known online eye-wear brand. Within the offline segment, the ophthalmology clinic/eye care centers generated the highest revenue owing to the rising awareness regarding the importance of getting eyes tested by a specialist. Regional Overview By region, the global Spectacle Lens market is divided into Asia Pacific, Europe, North America, Middle East & Africa, and South America. For more information about this report visit https://www.researchandmarkets.com/r/p5pog3 Contacts

CooperCompanies Acquisitions

9 Acquisitions

CooperCompanies acquired 9 companies. Their latest acquisition was Cook Medical - Reproductive Health Business on February 07, 2022.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

2/7/2022

$99M

Acquired Unit

3

11/11/2021

Subscribe to see more

$99M

Subscribe to see more

10

5/4/2021

Subscribe to see more

$99M

Subscribe to see more

10

3/1/2021

Subscribe to see more

$99M

Subscribe to see more

10

2/3/2021

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/7/2022

11/11/2021

5/4/2021

3/1/2021

2/3/2021

Investment Stage

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Total Funding

Note

Acquired Unit

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

3

10

10

10

10

CooperCompanies Service Providers

1 Service Provider

CooperCompanies has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Acquired Unit

Investment Bank

Sole Financial Advisor

Service Provider

Associated Rounds

Acquired Unit

Provider Type

Investment Bank

Service Type

Sole Financial Advisor

Partnership data by VentureSource

CooperCompanies Team

1 Team Member

CooperCompanies has 1 team member, including current Chief Operating Officer, Executive Vice President, Daniel McBride.

Name

Work History

Title

Status

Daniel McBride

Chief Operating Officer, Executive Vice President

Current

Name

Daniel McBride

Work History

Title

Chief Operating Officer, Executive Vice President

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.